The FDA has approved Oriahnn™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules; AbbVie) for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.
Compared with children who are naturally conceived, children who are conceived via assisted reproductive techniques (ART) may be at increased risk for mortality during their first year of life.
Researchers examined factors associated with returning to the use of assisted reproductive therapy for a second child and cycle-specific and cumulative live birth rates.
In a study, most symptomatic hypogonadal men treated with Natesto, a short-acting 4.5% nasal testosterone gel, attained normal testosterone levels at 6 months while preserving sperm counts.
Postmenopausal women with both bilateral salpingo-oophorectomy and a family history of premature myocardial infarction have an increased risk for heart disease mortality, especially those who underwent BSO at an earlier age.
Women with lower ovarian reserve do not experience differences in adiposity and glucose metabolism during their reproductive life span compared with women with high ovarian reserve.
An internet-based cognitive therapy intervention for women with infertility may reduce anxiety, depression, and stress and increase the likelihood of pregnancy.
Researchers studied the average age of menopause, prevalence of early menopause and premature menopause, and correlates of menopause occurring at <45 years in women living with HIV.
Higher levels of testosterone are associated with an increased risk of type 2 diabetes in women but play a protective role against type 2 diabetes in men.
